Influencing and shaping our sector BIA update Q2 2021

BIA’s ongoing engagement enables our members’ voices to be heard at the highest levels. This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences sector, from May to July 2021.

UK quoted biotech performance and investor base in 2021 (June update)

This report is an exclusive analysis of the performance of the UK-quoted biotech sector and the breadth of its investor base by Radnor Capital Partners on behalf of the BIA.

A guide to the Government for BIA members (2021)

BIA Response to the HMT R&D tax reliefs consultation

The BIA has responded to the HM Treasury review of R&D tax reliefs.